DENTSPLY SIRONA Inc. (XRAY) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-01-27

Key Insights

The reporting person, Donald Zurbay, is a director of DENTSPLY SIRONA Inc. and has acquired 6,871 shares of common stock in the form of restricted stock units (RSUs) that will vest fully in one year.
This transaction indicates that an insider of the company is receiving an equity-based compensation award, which could align their interests with those of shareholders.
The timing and size of this insider grant may provide insights into the company's financial performance and management's confidence in the future outlook.

Want the newest filings?

This analysis covers the filing from 2026-01-27. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-01-13

The reporting person, Clyde Hosein, is a director of DENTSPLY SIRONA Inc. (XRAY) and acquired 355.0455 shares of common stock through the vesting of restricted stock units (RSUs) and related dividend payments.
The acquisition of shares indicates that Hosein has confidence in the company and is increasing his ownership stake.
The transaction was made pursuant to a written plan and not due to opportunistic trading, suggesting it is part of a broader investment strategy.

Filed: 2026-01-13

The reporting person, Janet S. Vergis, acquired 200.899 shares of DENTSPLY SIRONA Inc. (XRAY) common stock through dividends on restricted stock units (RSUs).
The reported transaction was an acquisition of shares, which indicates a positive insider sentiment towards the company.
The number of shares acquired is relatively small, suggesting this transaction may not be a significant event for investors.

Filed: 2026-01-13

The reporting person, Leslie F. Varon, acquired 198.141 shares of Dentsply Sirona Inc. (XRAY) common stock on January 9, 2026 through the vesting of restricted stock units (RSUs).
The acquisition of shares represents additional RSUs granted as dividends on the underlying RSU awards, which are subject to the same vesting terms.
The reporting person now holds a total of 57,541.066 shares of Dentsply Sirona common stock in direct ownership.

Filed: 2026-01-13

The reporting person, Daniel T. Scavilla, acquired 245.816 shares of DENTSPLY SIRONA Inc. (XRAY) common stock in the form of restricted stock units (RSUs) as dividends on existing RSU awards.
Scavilla, who serves as the President, CEO, and a member of the Board of Directors, has direct beneficial ownership of 17,944.546 shares of XRAY following the reported transaction.
The acquisition of shares through RSU dividends suggests continued alignment between Scavilla's interests and those of DENTSPLY SIRONA shareholders.

Filed: 2026-01-13

The reporting person, Jonathan Jay Mazelsky, acquired 395.158 shares of Dentsply Sirona Inc. (XRAY) common stock through dividends on restricted stock units (RSUs), increasing his direct ownership to 28,846.534 shares.
Mazelsky also acquired 153.7009 shares of phantom stock through accrued dividends, which will be paid out in common stock upon his termination as a director.
The insider transaction suggests Mazelsky's continued confidence in the company's long-term prospects, as he is accumulating more equity through both RSUs and phantom stock.

Filed: 2026-01-13

Gregory T. Lucier, a director at DENTSPLY SIRONA Inc., acquired 341.114 shares of the company's common stock through dividends on restricted stock units (RSUs), increasing his indirect beneficial ownership to 24,901.284 shares.
Lucier also holds 21,000 shares of DENTSPLY SIRONA's common stock through his IRA account, indicating his commitment to the company.
The dividend-based acquisition of shares suggests Lucier's confidence in the company's performance and long-term prospects.

Filed: 2026-01-13

The reporting person, Robert Anthony Johnson, acquired 641.625 shares of common stock through dividend reinvestment on restricted stock units.
The reporting person now holds 116,313.146 shares of common stock, including 514 shares acquired through the employee stock purchase plan.
The reporting person also holds 3,113.1526 shares of phantom stock in the Supplemental Executive Retirement Plan, which will be paid out in common stock upon termination of employment.

Filed: 2026-01-13

Betsy D. Holden, a director of DENTSPLY SIRONA Inc., acquired 710.956 shares of the company's common stock through dividends on restricted stock units (RSUs).
The acquired shares increased Holden's direct beneficial ownership in the company to 54,613.852 shares.
The acquisition of shares through dividends on RSUs suggests that Holden is maintaining her investment in the company and aligning her interests with those of other shareholders.

Filed: 2026-01-13

The reporting person, Brian T. Gladden, acquired 314.959 shares of DENTSPLY SIRONA Inc. (XRAY) common stock in the form of additional restricted stock units (RSUs) as dividends on existing RSU awards.
The acquired RSUs are subject to the same vesting terms as the underlying awards and will convert to common stock on a 1:1 basis.
This transaction indicates that the reporting person, a director of the company, is maintaining their direct ownership stake in DENTSPLY SIRONA.

Filed: 2026-01-13

Andrea L. Frohning, the SVP and CHRO of DENTSPLY SIRONA Inc. (XRAY), acquired 392.387 shares of common stock through dividend reinvestment, increasing her direct beneficial ownership to 34,002.252 shares.
Frohning also acquired 22.7283 shares of phantom stock in the company's Supplemental Executive Retirement Plan (SERP), which will convert to common stock upon her termination of employment.
The insider transaction signals that Frohning has confidence in the company's future and is aligning her interests with those of DENTSPLY SIRONA's shareholders.

Filed: 2026-01-13

The reporting person, Willie A. Deese, acquired 201.508 shares of the issuer's common stock in the form of additional restricted stock units (RSUs) on January 9, 2026, indicating continued investment in the company.
The RSUs are subject to the same vesting terms as the underlying awards, suggesting the reporting person's long-term commitment to the issuer.
The acquisition of shares through dividends on RSUs, rather than direct purchases, suggests the reporting person's compensation structure is aligned with shareholders' interests.

Filed: 2026-01-13

The reporting person, Kevin Czerney, acquired 262.7169 additional shares of DENTSPLY SIRONA Inc. (XRAY) common stock through dividend reinvestment, indicating continued ownership and confidence in the company.
Czerney also received 4.0523 shares of phantom stock through the Dentsply Supplemental Savings Plan and 45.13 shares of phantom stock through the Supplemental Executive Retirement Plan, further aligning his interests with the company.
The transactions were executed on January 9, 2026, suggesting Czerney's ongoing involvement and commitment to DENTSPLY SIRONA as a key executive.

Filed: 2026-01-13

The filing shows that Michael J. Barber, a director at DENTSPLY SIRONA Inc. (XRAY), acquired 245.816 shares of common stock on January 9, 2026, potentially indicating his confidence in the company.
The shares were acquired in the form of additional restricted stock units (RSUs) as dividends on previously awarded RSUs, aligning Barber's interests with those of shareholders.
The transaction increases Barber's direct beneficial ownership in DENTSPLY SIRONA to 17,944.987 shares, suggesting he continues to have a significant stake in the company.

Other reports for DENTSPLY SIRONA Inc.

Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.